ES2913398T3 - Composiciones y métodos para el tratamiento o la prevención de trastornos relacionados con oxalato - Google Patents

Composiciones y métodos para el tratamiento o la prevención de trastornos relacionados con oxalato Download PDF

Info

Publication number
ES2913398T3
ES2913398T3 ES17730457T ES17730457T ES2913398T3 ES 2913398 T3 ES2913398 T3 ES 2913398T3 ES 17730457 T ES17730457 T ES 17730457T ES 17730457 T ES17730457 T ES 17730457T ES 2913398 T3 ES2913398 T3 ES 2913398T3
Authority
ES
Spain
Prior art keywords
oxalate
enteric
dry weight
coated capsule
capsule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES17730457T
Other languages
English (en)
Spanish (es)
Inventor
Elisabeth Lindner
Maria Åkerman
Anna Sjögren
Orla Mccallion
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxthera Intellectual Property AB
Original Assignee
Oxthera Intellectual Property AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxthera Intellectual Property AB filed Critical Oxthera Intellectual Property AB
Application granted granted Critical
Publication of ES2913398T3 publication Critical patent/ES2913398T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES17730457T 2016-06-13 2017-06-13 Composiciones y métodos para el tratamiento o la prevención de trastornos relacionados con oxalato Active ES2913398T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE1650828 2016-06-13
PCT/EP2017/064422 WO2017216165A1 (en) 2016-06-13 2017-06-13 Compositions and methods for the treatment or prevention of oxalate-related disorders

Publications (1)

Publication Number Publication Date
ES2913398T3 true ES2913398T3 (es) 2022-06-02

Family

ID=59067657

Family Applications (1)

Application Number Title Priority Date Filing Date
ES17730457T Active ES2913398T3 (es) 2016-06-13 2017-06-13 Composiciones y métodos para el tratamiento o la prevención de trastornos relacionados con oxalato

Country Status (12)

Country Link
US (2) US10765709B2 (https=)
EP (1) EP3468572B1 (https=)
JP (1) JP7016353B2 (https=)
CN (1) CN109641019A (https=)
AU (1) AU2017286220A1 (https=)
CA (1) CA3023042A1 (https=)
ES (1) ES2913398T3 (https=)
IL (1) IL263477A (https=)
JO (1) JOP20180110A1 (https=)
MA (1) MA45226A (https=)
TN (1) TN2018000420A1 (https=)
WO (1) WO2017216165A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3468572B1 (en) * 2016-06-13 2022-03-02 OxThera Intellectual Property AB Compositions and methods for the treatment or prevention of oxalate-related disorders
US20210386793A1 (en) * 2018-10-04 2021-12-16 Oxthera Intellectual Property Ab New medical use of oxalate-reducing bacteria
CN110607262B (zh) * 2019-09-25 2022-03-25 君维安(武汉)生命科技有限公司 一种干预炎性肠炎的益生菌组合物及其筛选方法和应用
EP3839039A1 (en) * 2019-12-16 2021-06-23 4D Pharma Research Limited Providing bacterial biomass with improved storage stability
BR112022013867A2 (pt) * 2020-01-14 2022-09-13 Synlogic Operating Co Inc Bactérias manipuladas para tratar distúrbios nos quais o oxalato é prejudicial
CA3175041A1 (en) * 2020-03-10 2021-09-16 Federation Bio Inc. Microbial consortia for the treatment of disease
EP4043018A1 (en) * 2021-02-10 2022-08-17 Charité - Universitätsmedizin Berlin Composition and method for reducing oxalate levels in patients receiving maintenance dialysis
CA3216136A1 (en) * 2021-04-30 2022-11-03 Aaron Blake Cowley Compositions for preserving anaerobic microorganisms and methods of making and using the same
WO2023102091A2 (en) * 2021-12-01 2023-06-08 Federation Bio, Inc. Microbial consortia

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5286495A (en) * 1992-05-11 1994-02-15 University Of Florida Process for microencapsulating cells
BG61712B1 (bg) * 1994-12-29 1998-04-30 "Ел Би Булгарикум" ЕАД закваски за българско кисело мляко и млечнокисели продукти и методи за получаването им
US6355242B1 (en) 1997-05-23 2002-03-12 Ixion Biotechnology, Inc. Materials and methods for treating or preventing oxalate-related disease
US8486389B2 (en) * 1997-05-23 2013-07-16 Oxthera, Inc. Compositions and methods for treating or preventing oxalate-related disease
JP4996780B2 (ja) 1997-05-23 2012-08-08 オクセラ インコーポレイテッド シュウ酸塩関連疾患を予防するためのシュウ酸塩分解微生物またはシュウ酸塩分解酵素
WO2005097176A2 (en) 2004-03-26 2005-10-20 University Of Florida Research Foundation, Inc. Modulating oxalate transport
CA2608862C (en) 2004-06-11 2020-05-05 Trustees Of Tufts College Silk-based drug delivery system
WO2007070052A2 (en) 2005-12-14 2007-06-21 Oxthera, Inc. Pharmaceutical compositions and methods for treating or preventing oxalate-related disease
JP5558002B2 (ja) 2005-12-16 2014-07-23 オクセラ インコーポレイテッド シュウ酸塩低減化のための組成物および方法
JP5193626B2 (ja) 2008-02-20 2013-05-08 日本曹達株式会社 微生物農薬製剤の保存方法
US9714456B2 (en) 2013-01-18 2017-07-25 Allena Pharmaceuticals, Inc. Crystallized oxalate decarboxylase and methods of use
EP3468572B1 (en) * 2016-06-13 2022-03-02 OxThera Intellectual Property AB Compositions and methods for the treatment or prevention of oxalate-related disorders

Also Published As

Publication number Publication date
US20190125807A1 (en) 2019-05-02
AU2017286220A1 (en) 2018-12-06
TN2018000420A1 (en) 2020-06-15
EP3468572A1 (en) 2019-04-17
WO2017216165A1 (en) 2017-12-21
CN109641019A (zh) 2019-04-16
JOP20180110A1 (ar) 2019-01-30
CA3023042A1 (en) 2017-12-21
US10765709B2 (en) 2020-09-08
US20210052670A1 (en) 2021-02-25
EP3468572B1 (en) 2022-03-02
IL263477A (en) 2019-01-31
JP2019521182A (ja) 2019-07-25
MA45226A (fr) 2019-04-17
JP7016353B2 (ja) 2022-02-04

Similar Documents

Publication Publication Date Title
ES2913398T3 (es) Composiciones y métodos para el tratamiento o la prevención de trastornos relacionados con oxalato
US11077078B2 (en) Compositions and methods for the treatment of cancer
Forsyth et al. Endoscopy of the gastroduodenal mucosa after carprofen, meloxicam and ketoprofen administration in dogs
ES2426258T3 (es) Composiciones farmacéuticas que comprenden bacterias que reducen oxalato
ES2606050T5 (en) Pharmaceutical composition comprising linagliptin and optionally a sglt2 inhibitor, and uses thereof
JP5583022B2 (ja) システアミン生成物を用いる非アルコール性脂肪性肝炎（ｎａｓｈ）の治療方法
TW202137988A (zh) 氧化膽固醇硫酸鹽（ｏｃｓ）之用途
JP7083835B2 (ja) 亜鉛－γ－ＰＧＡ組成物およびがんを処置するための方法
EP2391363A2 (en) Compositions and methods for the treatment of cancer
ES2822180T3 (es) Formulación farmacéutica que contiene glicosaminoglicano
TW200815022A (en) Bile preparations for colorectal disorders
ES2515215T3 (es) Tratamiento de la malabsorción de fructosa
US20210154161A1 (en) Modified-release bucillamine compositions, kits, and methods for treating cystinuria, arthritis, gout, and related disorders
CN115884764A (zh) 用于治疗乙型冠状病毒感染的半胱胺前体化合物
US20210386793A1 (en) New medical use of oxalate-reducing bacteria
ES2782523T3 (es) Cápsulas no digeribles para la administración de materiales absorbentes de líquido
ES2870718T3 (es) Formulación de liberación mantenida de la colchicina y métodos para establecer los mismos
WO2025012469A1 (en) Polymeric microparticles loaded with nanoparticles for the delivery of nucleic acids
WO2023209258A1 (es) Composición para la rehabilitación intestinal
Sjödahl et al. Crohn's disease